Page 6,718«..1020..6,7176,7186,7196,720..6,7306,740..»

Former Auburn coach getting stem cell treatments for Lou Gehrig's disease

Posted: Published on June 30th, 2012

MOBILE, Alabama -- The Baldwin County doctor that treated former Alabama football players with adult stem cells also has treated at least two people diagnosed with amyotrophic lateral sclerosis, also known as Lou Gehrigs disease. One of the ALS patients, former NFL football player and college coach Frank Orgel, recently underwent a new stem cell reprogramming technique performed by Dr. Jason R. Williams at Precision StemCell in Gulf Shores. Before the injections, Orgels health had declined. He could not move his left arm or leg. He couldnt walk or stand on his own, he said. Within a few days of having the stem cell treatment, Orgels constant muscle twitching diminished, said Bob Hubbard, director of stem cell therapy at the practice. Within weeks, he was able to walk in a pool of water and stand unassisted. I think its helped me, said Orgel, who was a defensive coordinator at Auburn under former head coach Pat Dye. Im walking in the pool and I used to drag my feet. Now my left leg is picking up. ALS is a progressive neuro-degenerative disease that affects nerve cells in the brain and the spinal cord. The progressive degeneration of the motor neurons in … Continue reading

Posted in Cell Medicine | Comments Off on Former Auburn coach getting stem cell treatments for Lou Gehrig's disease

Cell Press journals continue to deliver high impact

Posted: Published on June 30th, 2012

Public release date: 29-Jun-2012 [ | E-mail | Share ] Contact: Elisabeth (Lisa) Lyons elyons@cell.com 617-386-2121 Cell Press Latest annual citation reports confirm Cell Press delivers highly valued, highly cited research and reviews to the scientific community it serves We are delighted to report that the new impact factors align with community perception and confirm that Cell Press continues to publish the highest impact research and reviews in the biomedical sciences, according to the latest Journal Citation Reports published by Thomas Reuters. Cell Press's flagship journal Cell received an impressive impact factor of 32.403. Showing strong and steady growth, Cell's impact factor has increased by 9% since 2005, maintaining its status as the premier research journal in its field. Cell is currently ranked the number one research journal in the 'Cell Biology' and 'Biochemistry & Molecular Biology' categories. Over 70% of journals within the Trends review journal series increased in impact factor this year, with significant growth across several life science disciplines. Top performers include Trends in Cognitive Science, which increased by 30% to 12.586, Trends in Immunology, which grew 9% to 10.403, and Trends in Ecology and Evolution, which rose 9% to 15.748. Published by Cell Press since 2007, … Continue reading

Posted in Cell Medicine | Comments Off on Cell Press journals continue to deliver high impact

The More America Spends On The Drug War, The Cheaper Drugs Become

Posted: Published on June 30th, 2012

This week saw the release of a The War on Drugs and HIV/AIDS, a new report from the Global Commission on Drug Policy. The report's core finding is that the war on drugs has resulted in a spread of the HIV pandemic by driving drug users underground, and away from healthcare, and into high risk environments like prison. Perhaps most damningly, this has all happened without a noticeable affect on the drug trade itself. Illicit opiate production has grown 380% in recent decades, and in the US, drugs have become more cheaper and more potent since the drug war started despite the rising expenditure by the US government on the drug war. Here's how heroin purity and cost has changed during the drugs war (click to expand): And how cocaine price has changed during the drugs war (click to expand): Taken together, the studies authors conclude that "overall drug supply (as evidenced by various indicators of increasing production, declining prices and increasing potency) has been largely unimpeded by the multibillion dollar investments that have gone into trying to disrupt supply through costly policing, arrests and interdiction efforts." More From Business Insider See the rest here: The More America Spends On … Continue reading

Posted in Drugs | Comments Off on The More America Spends On The Drug War, The Cheaper Drugs Become

China Jo-Jo Drugstores, Inc. Postpones Fiscal 2012 Conference Call

Posted: Published on June 30th, 2012

HANGZHOU, China--(BUSINESS WIRE)-- China Jo-Jo Drugstores, Inc. (CJJD) (the Company), a retail pharmacy chain in Zhejiang and Shanghai, today announced that the Company will postpone its fiscal year 2012 earnings call originally scheduled on Monday, July 2, 2012 at 8 a.m. Eastern Time. The Company will announce the rescheduled time for the earnings call once it is set. About China Jo-Jo Drugstores, Inc. China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd., Shanghai Lydia Grand Pharmacy Co. Ltd., and Zhejiang Jiuying Grand Pharmacy Co. Ltd., operates a retail pharmacy chain in the Peoples Republic of China offering both western and traditional Chinese medicine and related products. As of June 26, 2012, the Company has 64 drugstores throughout Zhejiang Province and Shanghai. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as believe, expect, may, … Continue reading

Posted in Pharmacy | Comments Off on China Jo-Jo Drugstores, Inc. Postpones Fiscal 2012 Conference Call

Drug problem has grown since 1991 pharmacy robbery

Posted: Published on June 30th, 2012

The first pharmacy robbery I covered was on a slushy, gray day in December 1991. Pharmacy robberies were virtually unheard of, so interest in the newsroom was piqued at once. The robber didnt get far, just a couple of miles from the Downeast Pharmacy in Hampden to the parking lot of the former Burger King restaurant on Main Street in Bangor. He had stopped there to get a soda with which to swallow some of the 100 Percodan tablets he had stolen at knifepoint just about 10 minutes before. By the time I dashed down the block to Burger King, 73-year-old Emil Garrett already had assumed the position and was under arrest. Turned out Mr. Garrett was a very smart man a retired Army colonel and a chemical engineer but he also was an addict and, as it turned out, not a terribly swift robbery suspect. It was nine years later when the BDN ran its bold headline: Heroin. Its Cheap. Its Deadly. Its Here. Dealers find markets in Maine for addictive drug. Garrett wasnt using heroin, but what we all learned nine years after his failed robbery attempt was that heroin and prescription opiates are interchangeable. We also learned … Continue reading

Posted in Pharmacy | Comments Off on Drug problem has grown since 1991 pharmacy robbery

Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition

Posted: Published on June 30th, 2012

KIRKLAND, Wash., June 29, 2012 /PRNewswire/ --Talyst, a leader in pharmacy automation, announces AutoSplit Contract Pharmacy at the 16th Annual 340B Coalition. The conference highlights will include sessions devoted to program integrity and audits, key considerations when developing contract pharmacy relationships, how the 340B program helps improve and expand patient care, and practical steps and policy solutions to address drug shortages. AutoSplit Contract Pharmacy allows health systems to capture additional 340B savings from hospital scripts dispensed at retail pharmacies. The solution is an end-to-end managed service that gives covered entities the opportunity to capture increased 340B savings. "Disproportionate Share Hospitals (DSH) can benefit from a 340B program," said Carla Corkern, Chief Executive Officer at Talyst. "Through their additional savings from Contract Pharmacy, the DSH can provide better and safer care to their patients." Talyst will be exhibiting at the Coalition in booth #33. For more information on the conference, visit http://www.340bcoalition.org/conferences/2012_annual/index.cfm. About Talyst Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 … Continue reading

Posted in Pharmacy | Comments Off on Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition

Cell Press journals continue to deliver high impact

Posted: Published on June 30th, 2012

Public release date: 29-Jun-2012 [ | E-mail | Share ] Contact: Elisabeth (Lisa) Lyons elyons@cell.com 617-386-2121 Cell Press Latest annual citation reports confirm Cell Press delivers highly valued, highly cited research and reviews to the scientific community it serves We are delighted to report that the new impact factors align with community perception and confirm that Cell Press continues to publish the highest impact research and reviews in the biomedical sciences, according to the latest Journal Citation Reports published by Thomas Reuters. Cell Press's flagship journal Cell received an impressive impact factor of 32.403. Showing strong and steady growth, Cell's impact factor has increased by 9% since 2005, maintaining its status as the premier research journal in its field. Cell is currently ranked the number one research journal in the 'Cell Biology' and 'Biochemistry & Molecular Biology' categories. Over 70% of journals within the Trends review journal series increased in impact factor this year, with significant growth across several life science disciplines. Top performers include Trends in Cognitive Science, which increased by 30% to 12.586, Trends in Immunology, which grew 9% to 10.403, and Trends in Ecology and Evolution, which rose 9% to 15.748. Published by Cell Press since 2007, … Continue reading

Comments Off on Cell Press journals continue to deliver high impact

Ipo 8 weeks after stem cell therapy at Surf Paws Animal Hospital – Video

Posted: Published on June 30th, 2012

28-06-2012 13:54 About 5 months ago, she came home from the beach with my husband limping on her right back leg. Now 8 weeks later after stem cell therapy... we were happy (well, maybe not so much...) to see her back to her old, wild, hyper self again. Read more here: Ipo 8 weeks after stem cell therapy at Surf Paws Animal Hospital - Video … Continue reading

Comments Off on Ipo 8 weeks after stem cell therapy at Surf Paws Animal Hospital – Video

Stem Cell Therapy | Producers Direct | Kansas City, Missouri – Video

Posted: Published on June 30th, 2012

28-06-2012 14:46 Read more here: Stem Cell Therapy | Producers Direct | Kansas City, Missouri - Video … Continue reading

Comments Off on Stem Cell Therapy | Producers Direct | Kansas City, Missouri – Video

Researcher hunts for sickle cell anemia cure with gene targeting, stem cells

Posted: Published on June 30th, 2012

Halfway around the world in India, Sivaprakash Ramalingam had heard of Johns Hopkins researchers using a promising new technique for gene therapy that he hoped to integrate with stem cells to cure diseases. After getting a doctorate in biochemistry in his native country, he came to Baltimore four years ago to study under the technique's pioneer, Srinivasan Chandrasegaran, at Hopkins' Bloomberg School of Public Health. Ramalingam's research has led him down the path of seeking a cure for sickle cell anemia, a painful, life-shortening blood disorder that afflicts many in his home region in southern India. In the United States, the disease affects 70,000-100,000 people, mostly African-Americans, according to the National Heart Lung and Blood Institute. "I couldn't have done this type of research in India," said Ramalingam. "I wanted to use this technique with stem cells to treat disease." Ramalingam's research was given a lift last month by the state. He was one of 17 researchers who was funded by the Maryland Stem Cell Research Commission, a state entity that has doled out roughly $10 million to $12 million a year in taxpayer funds since its founding in 2006. The program helps keep Maryland competitive in stem cell research … Continue reading

Posted in Stem Cell Human Trials | Comments Off on Researcher hunts for sickle cell anemia cure with gene targeting, stem cells

Page 6,718«..1020..6,7176,7186,7196,720..6,7306,740..»